Skip to content

Penn Center for Innovation

  • Inventors
    • Disclose Your Invention
    • Commercializing Innovation
  • Entrepreneurs
    • PCI Startup Portfolio
    • PCI Ventures
    • Penn I-Corps
    • Penn and Greater Philadelphia’s Entrepreneurial Ecosystem & Resources
  • Partners
    • Search Penn Technologies
    • Corporate Alliances
    • Licensing
    • Partner with PCI
  • About
    • Contact PCI
    • Events
    • News
    • Metrics and Reports
    • PCI Fellows Program
    • Who We Are
  • Home

FDA approval of Passage Bio orphan drug

Posted on April 21, 2020

FDA grants Passage Bio orphan drug designation for PBGM01 for treatment of infantile GM1 Gangliosidosis.

Read More.

Posted in School of Medicine, StartupsTagged: External Stories

3600 Civic Center Blvd
9th Floor
Philadelphia, PA 19104

(215) 898-9591
pciinfo@pci.upenn.edu

  • Disclaimer
  • Copyright
  • Privacy Policy
  • Report Accessibility Issues & Get Help
  • Social Media Disclaimer